Pathology and current treatment of neurodegenerative sphingolipidoses. - Wikidata - awgldk - TriplyDB

Pathology and current treatment of neurodegenerative sphingolipidoses.

Pathology and current treatment of neurodegenerative sphingolipidoses.

http://www.wikidata.org/entity/Q37781746

about

Autophagy in lysosomal storage disorders The pleiotropic roles of sphingolipid signaling in autophagy Characterization of Drosophila Saposin-related mutants as a model for lysosomal sphingolipid storage diseases.Ceramide kinase-like (CERKL) interacts with neuronal calcium sensor proteins in the retina in a cation-dependent manner.Autophagy failure in Alzheimer's disease--locating the primary defect.Azasugar inhibitors as pharmacological chaperones for Krabbe disease Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases.Newborn screening for lysosomal storage disorders.Neuronopathic lysosomal storage diseases: clinical and pathologic findings.Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy.Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.

P2860

Q24601671-EEB40C40-B860-43CF-A0AD-A242EDF52F43 Q33720239-0D7D5CBE-B271-44EE-BD39-9A189574A9AC Q33830487-8F64EF48-05AC-4532-BB31-1D0C5CCA0B7B Q34296848-0A70349A-6AF3-4CD2-8425-460D8B050461 Q34987827-50B0A567-CF07-4202-9EF5-CB65A1900E3F Q35652295-020A6360-1B48-4632-8942-435502F243F0 Q37595934-7BB4DB03-B2F1-4B2A-92B9-29915E269EBA Q37839905-6873FB53-CF46-4B60-839F-CF5C94CDE649 Q38116812-18496443-EE30-456E-B185-6794E168AF01 Q39000126-F8237B46-C765-4154-8C54-B01D451AB598 Q44617144-6863676E-3142-4855-A5BC-7A58EDE35D25

P2860

Pathology and current treatment of neurodegenerative sphingolipidoses.

http://www.wikidata.org/entity/Q37781746

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pathology and current treatment of neurodegenerative sphingolipidoses.

@en

Pathology and current treatment of neurodegenerative sphingolipidoses.

@nl

type

label

Pathology and current treatment of neurodegenerative sphingolipidoses.

@en

Pathology and current treatment of neurodegenerative sphingolipidoses.

@nl

prefLabel

Pathology and current treatment of neurodegenerative sphingolipidoses.

@en

Pathology and current treatment of neurodegenerative sphingolipidoses.

@nl

P1433

Q37781746-29B06715-D645-4015-94AD-7723CA75DF5B

P1476

Q37781746-E8C9107F-0229-4382-95AB-7EA12200494B

P2093

Q37781746-C7006E0F-2857-4BE6-8870-9E2D57FD7C70

P2860

Q37781746-2D2585CC-49C0-4429-A6C4-74BBF1EEDF8F

Q37781746-2EBB8215-8111-4D4B-92F9-1844B99BDB87

Q37781746-55EDF7E9-65C4-4BC8-BCAE-7C3A43707BFB

Q37781746-666FFA3E-6C9E-4EA2-A174-481869AE2A00

Q37781746-729B7937-9D20-42A4-BF71-1D551277A96B

Q37781746-74EF5592-0BD5-4D66-BA8B-3D7D5286F819

Q37781746-95441F55-B283-49E8-9E0D-0BC9BC21709A

Q37781746-9E5A5EFF-BDA8-4F6D-A665-22147C6ADDB0

Q37781746-EFA002E9-5A26-4CF5-9F44-7BBFE15EB7B5

P2888

Q37781746-69C6A5CC-6218-443E-A76A-601C646B924F

P304

Q37781746-55DC8A73-53F0-40DF-8FBB-92CA0C77E32E

P31

Q37781746-F47C84F4-B758-424A-A995-41781FC3FD24

P356

Q37781746-CC98B16C-9C9A-4BF5-A4F9-D6D0C3E570B8

P433

Q37781746-928B4C65-FB7C-4D2D-99CD-D0B82CA15D67

P478

Q37781746-6A371A97-FAB8-47A7-BE5C-AB99232C4C41

P577

Q37781746-456A3B2E-1B19-4DB2-A903-C6153706072E

P698

Q37781746-8ADF2604-1462-47F4-B036-1B0721D945D2

P921

Q37781746-1f080da9-9afa-4181-9c8c-4d8a0b1e5021

Q37781746-8AF3F6EE-D7B5-422D-AED0-FCA9F1BD60B4

P356

S12017-010-8133-7

P1433

NeuroMolecular Medicine

P1476

Pathology and current treatment of neurodegenerative sphingolipidoses.

@en

P2093

Matthias Eckhardt

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary lipid accumulation in lysosomal disease.

Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Review of miglustat for clinical management in Gaucher disease type 1.

Autophagy: a lysosomal degradation pathway with a central role in health and disease.

The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases.

Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins.

Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease).

Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.

NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets

P2888

s12017-010-8133-7

P304

362-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12017-010-8133-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20730629

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration